U.S. flag

An official website of the United States government

NM_000546.6(TP53):c.638G>A (p.Arg213Gln) AND not provided

Germline classification:
Pathogenic (5 submissions)
Last evaluated:
Nov 16, 2021
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000420734.14

Allele description [Variation Report for NM_000546.6(TP53):c.638G>A (p.Arg213Gln)]

NM_000546.6(TP53):c.638G>A (p.Arg213Gln)

Gene:
TP53:tumor protein p53 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p13.1
Genomic location:
Preferred name:
NM_000546.6(TP53):c.638G>A (p.Arg213Gln)
HGVS:
  • NC_000017.11:g.7674893C>T
  • NG_017013.2:g.17658G>A
  • NM_000546.6:c.638G>AMANE SELECT
  • NM_001126112.3:c.638G>A
  • NM_001126113.3:c.638G>A
  • NM_001126114.3:c.638G>A
  • NM_001126115.2:c.242G>A
  • NM_001126116.2:c.242G>A
  • NM_001126117.2:c.242G>A
  • NM_001126118.2:c.521G>A
  • NM_001276695.3:c.521G>A
  • NM_001276696.3:c.521G>A
  • NM_001276697.3:c.161G>A
  • NM_001276698.3:c.161G>A
  • NM_001276699.3:c.161G>A
  • NM_001276760.3:c.521G>A
  • NM_001276761.3:c.521G>A
  • NP_000537.3:p.Arg213Gln
  • NP_000537.3:p.Arg213Gln
  • NP_001119584.1:p.Arg213Gln
  • NP_001119585.1:p.Arg213Gln
  • NP_001119586.1:p.Arg213Gln
  • NP_001119587.1:p.Arg81Gln
  • NP_001119588.1:p.Arg81Gln
  • NP_001119589.1:p.Arg81Gln
  • NP_001119590.1:p.Arg174Gln
  • NP_001263624.1:p.Arg174Gln
  • NP_001263625.1:p.Arg174Gln
  • NP_001263626.1:p.Arg54Gln
  • NP_001263627.1:p.Arg54Gln
  • NP_001263628.1:p.Arg54Gln
  • NP_001263689.1:p.Arg174Gln
  • NP_001263690.1:p.Arg174Gln
  • LRG_321t1:c.638G>A
  • LRG_321:g.17658G>A
  • LRG_321p1:p.Arg213Gln
  • NC_000017.10:g.7578211C>T
  • NM_000546.4:c.638G>A
  • NM_000546.5:c.638G>A
  • P04637:p.Arg213Gln
  • p.R213Q
Protein change:
R174Q
Links:
UniProtKB: P04637#VAR_005955; dbSNP: rs587778720
NCBI 1000 Genomes Browser:
rs587778720
Molecular consequence:
  • NM_000546.6:c.638G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126112.3:c.638G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126113.3:c.638G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126114.3:c.638G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126115.2:c.242G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126116.2:c.242G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126117.2:c.242G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126118.2:c.521G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276695.3:c.521G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276696.3:c.521G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276697.3:c.161G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276698.3:c.161G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276699.3:c.161G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276760.3:c.521G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276761.3:c.521G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000517027GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Pathogenic
(Nov 16, 2021)
germlineclinical testing

Citation Link,

SCV001449717Clinical Genetics and Genomics, Karolinska University Hospital
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Mar 27, 2018)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001469324Quest Diagnostics Nichols Institute San Juan Capistrano
criteria provided, single submitter

(Quest Diagnostics criteria)
Pathogenic
(Jan 13, 2020)
unknownclinical testing

PubMed (7)
[See all records that cite these PMIDs]

SCV001905965Clinical Genetics Laboratory, Department of Pathology, Netherlands Cancer Institute - VKGL Data-share Consensus

See additional submitters

no assertion criteria provided
Pathogenicgermlineclinical testing

SCV001953963Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ - VKGL Data-share Consensus

See additional submitters

no assertion criteria provided
Pathogenicgermlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.

Desmond A, Kurian AW, Gabree M, Mills MA, Anderson MJ, Kobayashi Y, Horick N, Yang S, Shannon KM, Tung N, Ford JM, Lincoln SE, Ellisen LW.

JAMA Oncol. 2015 Oct;1(7):943-51. doi: 10.1001/jamaoncol.2015.2690.

PubMed [citation]
PMID:
26270727
See all PubMed Citations (8)

Details of each submission

From GeneDx, SCV000517027.7

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Published functional studies demonstrate a damaging effect: partial to non-functional transactivation activity, deficient in targeting the consensus binding sequencing of p53 in the regulatory region of the p21 gene, resulting in an inability to up-regulate cell cycle arrest and apoptosis (Pan 2000, Kato 2003, Monti 2011, Zhang 2014, Kotler 2018); Not observed at significant frequency in large population cohorts (Lek 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; In-silico analysis is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; This variant is associated with the following publications: (PMID: 25268584, 16494995, 29979965, 28472496, 30224644, 28643165, 29058986, 25925845, 10871862, 14583457, 23259501, 16736287, 19468865, 8080050, 24728327, 1915267, 8492087, 21343334, 17606709, 24384472, 26270727, 26829319, 20522432, 28369373, 29076966, 18208484, 28861920, 29489754, 28724667, 30455982, 30675318, 30299350, 30720243, 30840781, 31119730, 30577483, 31481248, 31105275, 31447099, 33138793, 33818021, 17541742, 15510160)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Clinical Genetics and Genomics, Karolinska University Hospital, SCV001449717.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

From Quest Diagnostics Nichols Institute San Juan Capistrano, SCV001469324.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

The best available variant frequency is uninformative because there are too few occurrences in population data. Found in at least one patient with expected phenotype for this gene. Predicted to have a damaging effect on the protein. Located in potentially critical domain of the protein. Two other pathogenic or likely pathogenic variants affect the same amino acid. Assessment of experimental evidence suggests this variant results in abnormal protein function. Inconclusive segregation with disease

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Clinical Genetics Laboratory, Department of Pathology, Netherlands Cancer Institute - VKGL Data-share Consensus, SCV001905965.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ - VKGL Data-share Consensus, SCV001953963.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 12, 2024